Convalescent plasma is an experimental procedure for Coronavirus patients.
The Delhi government has received approval from the Union Health Ministry to use convalescent plasma technique on trial basis to save the life of severely-ill COVID-19 patients. The clinical trial of the plasma enrichment technique will be conducted at the Institute of Liver and Biliary Sciences (ILBS), according to an official.
In a tweet, Lt Governor Anil Baijal said that the officials concerned have been advised to strictly adhere to guidelines and protocols issued by the Ministry of Health and Family Welfare while dealing with coronavirus patients.
Delhi to use plasma technique for treatment on trial basis to save life of critical COVID-19 patients.
Advised all to strictly adhere to SOPs/guidelines & protocols issued by MoHFW while dealing with COVID-19 patients.
— LG Delhi (@LtGovDelhi) April 15, 2020
“Delhi to use plasma technique for treatment on trial basis to save life of critical COVID-19 patients. Advised all to strictly adhere to SOPs/guidelines & protocols issued by MoHFW while dealing with COVID-19 patients,” the LG tweeted.
The official said a five-member committee headed by ILBS Director S K Sarin had recommended use of this therapy to treat severally-ill coronavirus patients.
Earlier this month, the Indian Council of Medical Research (ICMR) sought participation in a randomised controlled study to assess the safety and efficacy of convalescent plasma to limit complications associated with coronavirus.
In the technique, antibodies from blood of patients, who have recovered from coronavirus, are used to treat severely infected patients. It is aimed at assessing the efficacy of convalescent plasma to limit complications in COVID-19 patients.
The total number of COVID-19 cases increased to 1578, with 17 fresh cases and two deaths being reported in a day, according to Delhi government authorities. With two more fatalities reported, the death toll from COVID-19 in Delhi has jumped to 32.